The treatment with Allelock® (Olopatadine hydrochloride) for patients with factitious urticaria

Nishinihon Journal of Dermatology

Volumn 65, Issue 2, 2003, Pages 172-174

  Morita, Eishin ^a   Matsuo, Hiroaki ^a   Dekio, Satoshi ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; OLOPATADINE;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CHRONIC URTICARIA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; FACTITIOUS URTICARIA; FEMALE; HUMAN; MALE; MECHANICAL STIMULATION; SKIN DISEASE;

EID: 0037278321     PISSN: 03869784     EISSN: None     Source Type: Journal    
DOI: 10.2336/nishinihonhifu.65.172     Document Type: Article

References (8)

1. Wong RC: Dermographism: a review. J Am Acad Dermatol 11: 643-652, 1984.
2. Ikemura T et al: KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils. Int Arch Allergy Immunol 110: 57-63, 1996.